| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Virology, November 2006, p. 10772-10786, Vol. 80, No. 21
0022-538X/06/$08.00+0 doi:10.1128/JVI.00804-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Abel Viejo-Borbolla,1,
and
Thomas F. Schulz1*
Institut für Virologie, Medizinische Hochschule Hannover, Carl-Neuberg Str. 1, D-30625 Hannover, Germany Department of Pathology, Harvard Medical School, Boston, Massachusetts
Received 19 April 2006/ Accepted 13 August 2006
The Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated
nuclear antigen 1 (LANA-1) is required for the replication of episomal
viral genomes. Regions in its N-terminal and C-terminal domains mediate
the interaction with host cell chromatin. Several cellular nuclear
proteins, e.g., BRD2/RING3, histones H2A and H2B, MeCP2, DEK, and
HP1
, have been suggested to mediate this interaction. In this
work, we identify the double-bromodomain proteins BRD4 and BRD3/ORFX as
additional LANA-1 interaction partners. The carboxy-terminal region of
the short variant of BRD4 (BRD4S) containing the highly
conserved extraterminal domain directly interacts with an element in
the LANA-1 carboxy-terminal domain. We show that ectopically expressed
BRD4S and BRD2/RING3 delay progression into the S phase of
the cell cycle in epithelial and B-cell lines and increase cyclin E
promoter activity. LANA-1 partly releases epithelial and B cells from a
BRD4S- and BRD2/RING3-induced G1 cell cycle
arrest and also promotes S-phase entry in the presence of
BRD4S and BRD2/RING3. This is accompanied by a reduction in
BRD4S-mediated cyclin E promoter activity. Our data are in
keeping with the notion that the direct interaction of KSHV LANA-1 with
BRD4 and other BRD proteins could play a role in the G1/S
phase-promoting functions of KSHV LANA-1. Further, our data support a
model in which the LANA-1 C terminus contributes to a functional
attachment to acetylated histones H3 and H4 via BRD4 and BRD2, in
addition to the recently demonstrated direct interaction (A.
J. Barbera, J. V. Chodaparambil, B. Kelley-Clarke, V. Joukov,
J. C. Walter, K. Luger, and K. M. Kaye, Science
311:856-861, 2006) of the LANA-1 N terminus with histones H2A
and
H2B.
Published ahead of print on 23 August 2006.
Present
address: Whitehead Institute, Massachusetts Institute of Technology,
Cambridge, MA.
Present
address: Department of Cell and Molecular Biology, Centro Nacional de
Biotecnologia, CSIC, Madrid, Spain.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|